Literature DB >> 24083797

Transapical aortic valve implantation: learning curve with reduced operating time and radiation exposure.

Giuseppe D'Ancona1, Miralem Pasic2, Axel Unbehaun1, Stephan Dreysse1, Thorsten Drews1, Semih Buz1, Marian Kukucka1, Alexander Mladenow1, Roland Hetzer1, Burkhardt Seifert3.   

Abstract

BACKGROUND: The purpose of this study was to test whether, and in which terms, the cumulative institutional experience in the field of transapical transcatheter aortic valve implantation (TAVI) might impact upon operative time and radiation exposure.
METHODS: This was a retrospective, single-center, observational cohort study of prospectively collected data from all 500 consecutive high-risk patients undergoing transapical TAVI at our institution between April 2008 and December 2011. Differences during the study period in baseline characteristics, procedural and post-procedural variables, and survival were analyzed. Nonparametric correlation and linear regression analyses were used to identify changes in operative time, contrast agent use, and radiation exposure according to institutional cumulative experience.
RESULTS: Median operating time was 90 minutes (interquartile range 75-115 min) and fluoroscopy time was 6.7 minutes (4.8-10.3 min). Combined planned percutaneous coronary intervention was performed in 57 (11.4%) patients. There was a significant correlation between operating time, fluoroscopy time, and institutional experience. A 5% reduction in operating time (95% CI 3% to 8%, p < 0.0001) and 15% reduction in radiation exposure time (95% CI 12% to 18%, p < 0.0001) was reported per 100 procedures performed.
CONCLUSIONS: After introduction and implementation of a structured training program for transapical TAVI, operating time and radiation exposure are contained and reduced over the entire observation time in 500 consecutive patients.
Copyright © 2014 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  35

Mesh:

Substances:

Year:  2013        PMID: 24083797     DOI: 10.1016/j.athoracsur.2013.07.070

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  4 in total

1.  Temporal Trends in Quality of Life Outcomes After Transapical Transcatheter Aortic Valve Replacement: A Placement of AoRTic TraNscathetER Valve (PARTNER) Trial Substudy.

Authors:  Hemal Gada; Ajay J Kirtane; Kaijun Wang; Yang Lei; Elizabeth Magnuson; Matthew R Reynolds; Mathew R Williams; Susheel Kodali; Torsten P Vahl; Suzanne V Arnold; Martin B Leon; Vinod Thourani; Wilson Y Szeto; David J Cohen
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2015-06-09

2.  Learning curves for transapical transcatheter aortic valve replacement in the PARTNER-I trial: Technical performance, success, and safety.

Authors:  Rakesh M Suri; Sa'ar Minha; Oluseun Alli; Ron Waksman; Charanjit S Rihal; Lowell P Satler; Kevin L Greason; Rebecca Torguson; Augusto D Pichard; Michael Mack; Lars G Svensson; Jeevanantham Rajeswaran; Ashley M Lowry; John Ehrlinger; Stephanie L Mick; E Murat Tuzcu; Vinod H Thourani; Raj Makkar; David Holmes; Martin B Leon; Eugene H Blackstone
Journal:  J Thorac Cardiovasc Surg       Date:  2016-04-13       Impact factor: 5.209

3.  Assessing the level of radiation experienced by anesthesiologists during transfemoral Transcatheter Aortic Valve Implantation and protection by a lead cap.

Authors:  N Patrick Mayr; Gunther Wiesner; Angela Kretschmer; Johannes Brönner; Herbert Hoedlmoser; Oliver Husser; Albert M Kasel; Rüdiger Lange; Peter Tassani-Prell
Journal:  PLoS One       Date:  2019-01-30       Impact factor: 3.240

4.  Noninvasive ventilation during left atrial appendage closure under sedation: Preliminary experience with the Janus Mask.

Authors:  Alberto Zangrillo; Patrizio Mazzone; Alessandro Oriani; Marina Pieri; Giovanna Frau; Giuseppe D'Angelo; Chiara Sartini; Riccardo Capucci; Alessandro Belletti; Paolo Della Bella; Fabrizio Monaco
Journal:  Ann Card Anaesth       Date:  2019 Oct-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.